| 1 |
Lee SS, Cheah YK. The interplay between microRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression[J]. J Immunol Res, 2019, 19(1): 3046379.
|
| 2 |
Nitanda H, Taguchi R, Yanagihara A, et al. [Surgical outcome of sublobar resection in high-risk patients with non-small cell lung cancer][J]. Kyobu Geka, 2019, 72(1): 17-22.
|
| 3 |
Dong S, Roberts SA, Chen S, et al. Survival after lobectomy versus sub-lobar resection in elderly with stage I NSCLC: a meta-analysis[J]. BMC Surg, 2019, 19(1): 38.
|
| 4 |
Liu J, Shi Z, Ma Y, et al. MOB1 inhibits malignant progression of colorectal cancer by targeting PAK2[J]. Onco Targets Ther, 2020, 13(1): 8803-8811.
|
| 5 |
Zhang J, Wu L, Lian C, et al. Nitidine chloride possesses anticancer property in lung cancer cells through activating Hippo signaling pathway[J]. Cell Death Discov, 2020, 6(1): 91.
|
| 6 |
Ando N, Tanaka K, Otsubo K, et al. Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer[J]. Thorac Cancer, 2020, 11(10): 2830-2839.
|
| 7 |
Dietel M, Bubendorf L, Dingemans AM, et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European expert group[J]. Thorax, 2016, 71(2): 177-184.
|
| 8 |
非小细胞肺癌辅助治疗胸外科共识专家组. 非小细胞肺癌术后辅助治疗中国胸外科专家共识(2018版)[J]. 中国肺癌杂志，2018, 21(10): 731-737.
|
| 9 |
Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update[J]. Discov Med, 2019, 27(148): 167-170.
|
| 10 |
Tandberg DJ, Tong BC, Ackerson BG, et al. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review[J]. Cancer, 2018, 124(4): 667-678.
|
| 11 |
Gundogdu R, Hergovich A. MOB (Mps one Binder) proteins in the Hippo pathway and cancer[J]. Cells, 2019, 8(6): 569.
|
| 12 |
Kato W, Nishio M, To Y, et al. MOB1 regulates thymocyte egress and T-cell survival in mice in a YAP1-independent manner[J]. Genes Cells, 2019, 24(7): 485-495.
|
| 13 |
Yang H, Hu J, Chen J, et al. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer[J]. Med Oncol, 2020, 37(9): 84.
|
| 14 |
Song J, Wang T, Chi X, et al. Kindlin-2 inhibits the Hippo signaling pathway by promoting degradation of MOB1[J]. Cell Rep, 2019, 29(11): 3664-3677.
|
| 15 |
Sasaki H, Kawano O, Endo K, et al. Human MOB1 expression in non-small-cell lung cancer[J]. Clin Lung Cancer, 2007, 8(4): 273-276.
|
| 16 |
Otsubo K, Goto H, Nishio M, et al. MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation[J]. Oncogene, 2017, 36(29): 4201-4211.
|
| 17 |
Taha Z, Janse van Rensburg HJ, Yang X. The Hippo pathway: immunity and cancer[J]. Cancers (Basel), 2018, 10(4): 94.
|
| 18 |
Ma S, Meng Z, Chen R, et al. The Hippo pathway: biology and pathophysiology[J]. Annu Rev Biochem, 2019, 88: 577-604.
|
| 19 |
Zheng Y, Pan D. The Hippo signaling pathway in development and disease[J]. Dev Cell, 2019, 50(3): 264-282.
|
| 20 |
Misra JR, Irvine KD. The Hippo signaling network and its biological functions[J]. Annu Rev Genet, 2018, 52(1): 65-87.
|
| 21 |
Boopathy GTK, Hong W. Role of Hippo pathway-YAP/TAZ signaling in angiogenesis[J]. Front Cell Dev Biol, 2019, 7(1): 49.
|
| 22 |
Driskill JH, Pan D. The Hippo pathway in liver homeostasis and pathophysiology[J]. Annu Rev Pathol, 2021, 16(1): 299-322.
|
| 23 |
Rausch V, Hansen CG. The Hippo pathway, YAP/TAZ, and the plasma membrane[J]. Trends Cell Biol, 2020, 30(1): 32-48.
|
| 24 |
Yamauchi T, Moroishi T. Hippo pathway in mammalian adaptive immune system[J]. Cells, 2019, 8(5): 398.
|
| 25 |
Kulaberoglu Y, Lin K, Holder M, et al. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control[J]. Nat Commun, 2017, 8(1): 695.
|
| 26 |
Kim E, Kang JG, Kang MJ, et al. O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity[J]. Proc Natl Acad Sci USA, 2020, 117(25): 14259-14269.
|
| 27 |
Hergovich A. Hippo signaling in mitosis: An updated view in light of the MEN pathway[J]. Methods Mol Biol, 2017, 1505(1): 265-277.
|
| 28 |
Zhang G, Dai S, Chen Y, et al. Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro[J]. Biomed Pharmacother, 2021, 138(1): 111506.
|